Effects of Metyrapone in Patients With Endogenous Cushing's Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

November 30, 2019

Study Completion Date

April 29, 2020

Conditions
Cushing's Syndrome
Interventions
DRUG

metyrapone

Single arm study

Trial Locations (36)

10043

San Luigi Gonzaga Hospital, University of Turin, Orbassano

10062

State health center, Budapest

10117

Charité Berlin, Berlin

Unknown

University hospital Antwerp, Antwerp

CHU Erasme, Brussels

University hospital Saint Luc, Brussels

CHU Liège, Liège

Universitätsklinikum Essen, Essen

Munich university, Munich

University hospital Wuerzburg, Würzburg

Semmelweis Egyetem II. Belgyógyászati Klinika, Budapest

University Debrecen, Debrecen

University of Pecs, Pécs

University of Szeged, Szeged

Grande Ospedale Metropolitano Niguarda, Milan

Ospedale San Luca IRCCS Istituto Auxologico Italiano, Milan

S. Giuseppe Hospital, Milan

Federico II University, Naples

University of Padova, Padua

University of Turin, Turin

Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice

University Hospital, Krakow

University Clinical Hospital, Wroclaw

Institutul National de Endocrinologie 'C.I Parhon' - Endocrinologie II, Bucharest

Institutul National de Endocrinologie 'C.I Parhon' - Endocrinologie VI, Bucharest

Spitalul Universitar de Urgenta Militar Central 'Dr Carol Davila', Bucharest

Spitalul Clinic Judetean de Urgenta Cluj-Napoca, Cluj-Napoca

S.C Centrul Clinic Mediquest SRL, Sângeorgiu de Mureş

Spitalul Clinic Judetean de Urgenta Sibiu, Sibiu

Spitalul Clinic Judetean Mures, Târgu Mureş

University hospital clinic of Barcelona, Barcelona

Hospital Universitario La Ribera, Valencia

Ankara Numune Training and Research Hospital, Ankara

Dokuz Eylul UMF, Izmir

Ondokuz Mayıs University Medical Faculty, Samsun

Karadeniz Teknik University, Trabzon

Sponsors

Lead Sponsor

All Listed Sponsors
lead

HRA Pharma

INDUSTRY

NCT02297945 - Effects of Metyrapone in Patients With Endogenous Cushing's Syndrome | Biotech Hunter | Biotech Hunter